Aly M Abdelrahman

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Anti Inflammatory

Top Venues

Naunyn-Schmiedeberg's archives of pharmacology

Fundamental & clinical pharmacology

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Amira M Helwani, Yousuf M Al Suleimani, Khalid Al Baimani, Aly M Abdelrahman
Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Aly M Abdelrahman, Badreldin H Ali, Haytham Ali, Priyadarsini Manoj, Yousuf Al-Suleimani
The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats. Fundamental & clinical pharmacology (2022)
Aly M Abdelrahman, Yousuf Al Suleimani, Asem Shalaby, Mohammed Ashique, Priyadarsini Manoj, Badreldin H Ali
Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats. Naunyn-Schmiedeberg's archives of pharmacology 392 (8) (2019)
Aly M Abdelrahman, Yousuf Al Suleimani, Asem Shalaby, Mohammed Ashique, Priyadarsini Manoj, Abderrahim Nemmar, Badreldin H Ali
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice. Naunyn-Schmiedeberg's archives of pharmacology 392 (1) (2018)